| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,310 | 0,446 | 19:04 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | ADVANCE ZINCTEK LIMITED: Change of Director's Interest Notice - Lev Mizikovsky | 1 | ASX | ||
| Di | ADVANCE ZINCTEK LIMITED: Change of Director's Interest Notice - Lev Mizikovsky | 2 | ASX | ||
| 23.10. | ADVANCE ZINCTEK LIMITED: Change of Director's Interest Notice - Lev Mizikovsky | 1 | ASX | ||
| 22.10. | ADVANCE ZINCTEK LIMITED: Change of Director's Interest Notice - Lev Mizikovsky | 1 | ASX | ||
| 20.10. | ADVANCE ZINCTEK LIMITED: Change of Director's Interest Notice - Lev Mizikovsky | - | ASX | ||
| 15.10. | ADVANCE ZINCTEK LIMITED: Change of Director's Interest Notice - Lev Mizikovsky | 1 | ASX | ||
| 14.10. | ADVANCE ZINCTEK LIMITED: Change of Director's Interest Notice - Lev Mizikovsky | 1 | ASX | ||
| 08.10. | ADVANCE ZINCTEK LIMITED: First Quarter FY27 Australian Revenue Down 71% | - | ASX | ||
| ADVANCE ZINCTEK Aktie jetzt für 0€ handeln | |||||
| 31.08. | Advance Zinctek Ltd Profit Advances In Full Year | 1 | RTTNews | ||
| 31.08. | ADVANCE ZINCTEK LIMITED: Corporate Governance Statement | 1 | ASX | ||
| 31.08. | ADVANCE ZINCTEK LIMITED: Appendix 4G | 1 | ASX | ||
| 31.08. | ADVANCE ZINCTEK LIMITED: Annual Report to shareholders | 1 | ASX | ||
| 31.08. | ADVANCE ZINCTEK LIMITED: Appendix 4E | 2 | ASX | ||
| 04.08. | ADVANCE ZINCTEK LIMITED: Change of Director's Interest Notice - Lev Mizikovsky | 1 | ASX | ||
| 31.07. | ADVANCE ZINCTEK LIMITED: Change of Director's Interest Notice - Lev Mizikovsky | - | ASX | ||
| 22.07. | ADVANCE ZINCTEK LIMITED: Change of Director's Interest Notice - Lev Mizikovsky | - | ASX | ||
| 20.07. | Advance ZincTek (ASX:ANO) lifts pre-tax profit 13% as enquiry pipeline builds | 2 | Stocks Down Under | ||
| 20.07. | ADVANCE ZINCTEK LIMITED: FY26 Unaudited Profit Before Tax Up 13% on Prior Year | - | ASX | ||
| 01.07. | ADVANCE ZINCTEK LIMITED: Change of Director's Interest Notice - Lev Mizikovsky | - | ASX | ||
| 30.06. | ADVANCE ZINCTEK LIMITED: Change of Director's Interest Notice - Lev Mizikovsky | - | ASX |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FORMYCON | 18,780 | -0,42 % | BERENBERG stuft Formycon auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat Formycon mit einem Kursziel von 30 Euro auf "Buy" belassen. Dass die US-Arzneimittelbehörde FDA einen Zulassungsantrag für FYB206 - das erste... ► Artikel lesen | |
| GAUZY | 5,990 | +2,74 % | GAUZY LTD: Gauzy Announces Receipt of Delisting Notice from Nasdaq; Intends to Appeal | TEL AVIV, Israel, Sept. 21, 2026 (GLOBE NEWSWIRE) -- Gauzy Ltd. (Nasdaq: GAUZ) ("Gauzy" or the "Company"), a global leader in vision and light control technologies, today announced receipt of a delisting... ► Artikel lesen | |
| ONTO INNOVATION | 180,90 | +0,33 % | Aletheia Capital initiates Nanometrics stock with buy on ALD growth | ||
| GOMSPACE | 1,175 | -1,43 % | GomSpace A/S: Ukraine's Sovereign Satellite Now Operating in Orbit | Ukraine's Sovereign Satellite Now Operating in Orbit
HIMERA and GomSpace launched it under the OBRIA Initiative.STOCKHOLM, Oct. 27, 2026 /PRNewswire/ -- Ukraine's HIMERA and Denmark's GomSpace... ► Artikel lesen | |
| KOPIN | 3,206 | -5,23 % | Fabric.AI (Nasdaq: FABC) Stockholders Ratify Kopin Strategic Partnership to Develop Neural I/o MicroLED Optical Interconnect Technology for Next Generation AI Data Centers | NEW YORK, NY, June 24, 2026 (GLOBE NEWSWIRE) -- Fabric.AI, Inc. (Nasdaq: FABC) ("Fabric.AI" or the "Company"), a fabless semiconductor company developing MicroLED-based optical interconnects for AI... ► Artikel lesen | |
| OBDUCAT | 0,029 | 0,00 % | NGM MARKET NOTICE: #26-72 Decision by the Disciplinary Committee regarding Obducat AB (publ) | ||
| RIBER | 5,970 | 0,00 % | Riber Reports Improved Results For The First Half Of 2026 | RIBER REPORTS IMPROVED RESULTS FOR THE FIRST HALF OF 2026 Revenues of €12.7m (+19%) and gross margin of €5.1m (+31%), representing 39.8% of revenuesPositive net income of €0.2m, compared with -€0.8m... ► Artikel lesen | |
| NANOFORM FINLAND | 0,766 | +17,85 % | Nanoform Finland Oyj: Nanoform Q2 2026 - Positive feedback from scientific advice meeting in the UK, significantly improved cash flow and discussions with CDMOs on sterile GMP for our Biologics technology initiated | Nanoform Finland Plc | Company Release | August 20, 2026 at 08:10:00 EEST
Nanoenzalutamide project continues with the communicated multitrack strategy supported by all partners. After a positive scientific... ► Artikel lesen | |
| SOLESENCE | 0,850 | 0,00 % | Solésence, Inc.: Solésence Reports Second Quarter 2026 Financial Results | Quarterly Report Filed on Form 10-Q Company to Host Conference Call at 5:00 p.m. ET Today ROMEOVILLE, Ill., Aug. 19, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically... ► Artikel lesen | |
| SMOLTEK NANOTECH | 0,120 | -3,24 % | SMOLTEK NANOTECH HOLDING AB: Smoltek Now Traded on Nordic Growth Market (NGM) | ||
| VEECO INSTRUMENTS | 34,630 | 0,00 % | Veeco Instruments Inc.: Veeco Reports Second Quarter 2026 Financial Results | Second Quarter 2026 Highlights: Revenue of $193.5 million, compared with $166.1 million in the same period last yearGAAP net income of $11.9 million, or $0.18 per diluted share, compared with $11.7... ► Artikel lesen | |
| ACACIA RESEARCH | 3,840 | 0,00 % | ACACIA RESEARCH CORP - 10-Q, Quarterly Report | ||
| LAMPETIA | 0,141 | 0,00 % | EQS-Adhoc: Lampetia AG: Einigung über die Beendigung von Rechtsstreitigkeiten | EQS-Ad-hoc: Lampetia AG / Schlagwort(e): Sonstiges
Lampetia AG: Einigung über die Beendigung von Rechtsstreitigkeiten
16.07.2026 / 22:00 CET/CEST
Veröffentlichung einer Insiderinformation... ► Artikel lesen | |
| DOTZ NANO | 0,006 | -48,72 % | XFRA 57N: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILDOTZ NANO LTD 57N... ► Artikel lesen | |
| NANOVIRICIDES | 1,180 | -5,60 % | As Ebola Spreads to Multiple Countries, the Importance of NV-387 Oral Gummies Treatment Cannot be Understated - Phase II Clinical Trial Advancing Towards the Second Part, Says NanoViricides | SHELTON, CT / ACCESS Newswire / October 27, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing antiviral drugs that viruses cannot escape, explained... ► Artikel lesen |